1-4 of 4
Jill M. Vanak, ACNP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bendamustine Is Highly Active in Heavily Pre-Treated Relapsed and Refractory Hodgkin Lymphoma and Serves as a Bridge to Allogeneic Stem Cell Transplant.

Alison J. Moskowitz, MD, Paul A. Hamlin, Jr., MD, John Gerecitano, MD, PhD, Steven M. Horwitz, MD, Matthew Matasar, MD, Jessica Meikle, Ariela Noy, MD, Maria Lia Palomba, MD, Carol S. Portlock, MD, David J. Straus, MD, Jill M Vanak, ACNP, Andrew D. Zelenetz, MD, PhD, Craig H Moskowitz, MD
Journal: Blood
Blood (2009) 114 (22): 720.
https://doi.org/10.1182/blood.V114.22.720.720
Published: 2009
Journal Articles

Initial Remission Duration of Less Than 1 Year Is No Longer An Adverse Prognostic Factor for Patients with Relapsed HL Undergoing High Dose Therapy and Autologous Stem Cell Transplant: Results of a Combined Analysis From Two Large Transplant Centers.

Alison J. Moskowitz, MD, John Sweetenham, MD, Brian J. Bolwell, MD, Jocelyn C Maragulia, Jill M Vanak, ACNP, Craig H Moskowitz, MD, Stephen Smith, MD
Journal: Blood
Blood (2009) 114 (22): 3413.
https://doi.org/10.1182/blood.V114.22.3413.3413
Published: 2009
Journal Articles

Normalization of FDG-PET Pre-ASCT with Additional Non-Cross Resistant Chemotherapy Improves EFS in Patients with Relapsed and Primary Refractory Hodgkin Lymphoma-Memorial Sloan Kettering Protocol 04-047

Craig H. Moskowitz, MD, Stephen D. Nimer, Andrew D. Zelenetz, MD, PhD, Paul A. Hamlin, Jr., MD, Steven M. Horwitz, MD, Ariela Noy, MD, Carol S. Portlock, MD, David J. Straus, MD, John Gerecitano, MD, PhD, Tarun Kewalramani, MD, Jill M. Vanak, ACNP, Jocelyn C. Maragulia, Joachim Yahalom, MD
Journal: Blood
Blood (2008) 112 (11): 775.
https://doi.org/10.1182/blood.V112.11.775.775
Published: 2008
Journal Articles

Pre-Transplant Evaluation with Both CT and PET Following Second-Line Therapy Is Essential for Predicting Outcome in Patients with Transplant- Eligible Relapsed and Primary Refractory Hodgkin Lymphoma

Alison J. Moskowitz, MD, Stephen D. Nimer, Andrew D. Zelenetz, MD, PhD, Tarun Kewalramani, MD, Jill M Vanak, ACNP, Jocelyn c Maragulia, Joachim Yahalom, MD, Craig Moskowitz, MD
Journal: Blood
Blood (2008) 112 (11): 776.
https://doi.org/10.1182/blood.V112.11.776.776
Published: 2008